{"id":42622,"date":"2023-11-13T13:22:22","date_gmt":"2023-11-13T13:22:22","guid":{"rendered":"https:\/?p=42622"},"modified":"2023-11-13T13:22:22","modified_gmt":"2023-11-13T13:22:22","slug":"novo-nordisks-wegovy-data-boosts-stock-to-1-month-high","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/","title":{"rendered":"Novo Nordisk&#8217;s Wegovy Data Boosts Stock to 1-Month High"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Novo Nordisk (<a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/NVO\">NVO: NYE<\/a>) has developed an injectable obesity drug called Wegovy, which has gained significant investor attention after the release of impressive clinical trial data. Wegovy is a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the effects of a naturally occurring hormone responsible for regulating appetite and blood sugar levels.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/NVO\" target=\"_blank\" rel=\"noopener\">NVO Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"NVO\" data-theme=\"wt_bg_trans\" data-uid=\"141076729865521f9dcb5f765521f9dcb5f8\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<p><!-- STA Widget END --><\/p>\n<h2>Wegovy&#8217;s Impressive Clinical Trial Results:<\/h2>\n<p><span style=\"font-weight: 400;\">In the Phase 3 Semaglutide Treatment Effect in People with Obesity (STEP) trial, Wegovy exhibited extraordinary average weight loss of 17.4% in participants after 68 weeks of treatment, compared to a mere 2.4% in the placebo group. The achievement of such substantial weight loss marks a historical milestone in Phase 3 obesity trials.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Moreover, participants in the STEP trial reported tolerable side effects, predominantly mild and transient, including nausea, vomiting, and diarrhea. <\/span><span style=\"font-weight: 400;\">The remarkable results from the STEP trial have compelled analysts to revise their price targets for Novo Nordisk&#8217;s stock. Oppenheimer analysts raised their target from $60 to $70 per share, while Deutsche Bank analysts increased their target from $55 to $65 per share.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The significance surrounding Wegovy is easily understandable, considering the vast and growing market for obesity treatments. The World Health Organization estimates that more than 1.9 billion adults worldwide are either overweight or obese. In the United States alone, the prevalence of obesity has more than doubled since 1970, affecting over 40% of adults.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Given factors such as population growth, aging, and urbanization, the obesity market is expected to witness substantial growth in the coming years. Consequently, Wegovy has the potential to become a blockbuster drug for Novo Nordisk.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Investment Implications and Risks:<\/strong><\/h2>\n<p><span style=\"font-weight: 400;\">The strong clinical trial data for Wegovy and the recent boost in European shares present promising prospects for Novo Nordisk. Investors with a bullish outlook on the obesity market and the healthcare sector should consider including Novo Nordisk in their portfolios.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, it is crucial to acknowledge the following risks:<\/span><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Wegovy has not yet received approval from the FDA, making its success uncertain.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Even if approved, Wegovy may face competition from other obesity drugs, such as Eli Lilly&#8217;s Tirzepatide.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Novo Nordisk&#8217;s stock trades at a relatively high price-to-earnings ratio of over 30.<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><strong>Conclusion:<\/strong><\/h2>\n<p><span style=\"font-weight: 400;\">Novo Nordisk is a leading pharmaceutical company renowned for its innovative track record. With its strong positioning in the growing market for obesity treatments, Novo Nordisk stands to benefit tremendously. Investors with a positive outlook on the obesity market and the healthcare sector should consider adding Novo Nordisk to their portfolios.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novo Nordisk (NVO: NYE) has developed an injectable obesity drug called Wegovy, which has gained significant investor attention after the release of impressive clinical trial&#8230;<\/p>\n","protected":false},"author":17,"featured_media":42624,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-42622","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Novo Nordisk&#039;s Wegovy Data Boosts Stock to 1-Month High | Stock Target Advisor<\/title>\n<meta name=\"description\" content=\"Novo Nordisk stock jumps on positive Wegovy data, hitting a 1-month high. Learn more about Wegovy and its potential impact on the company!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk&#039;s Wegovy Data Boosts Stock to 1-Month High\" \/>\n<meta property=\"og:description\" content=\"Novo Nordisk stock jumps on positive Wegovy data, hitting a 1-month high. Learn more about Wegovy and its potential impact on the company!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-13T13:22:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/11\/Novo-Nordisks-Wegovy-Data-Boosts-Stock-to-1-Month-High.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Muzzammil Ahmad\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/x.com\/Muzzammil625\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Muzzammil Ahmad\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/\"},\"author\":{\"name\":\"Muzzammil Ahmad\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\"},\"headline\":\"Novo Nordisk&#8217;s Wegovy Data Boosts Stock to 1-Month High\",\"datePublished\":\"2023-11-13T13:22:22+00:00\",\"dateModified\":\"2023-11-13T13:22:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/\"},\"wordCount\":413,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/\",\"name\":\"Novo Nordisk's Wegovy Data Boosts Stock to 1-Month High | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2023-11-13T13:22:22+00:00\",\"dateModified\":\"2023-11-13T13:22:22+00:00\",\"description\":\"Novo Nordisk stock jumps on positive Wegovy data, hitting a 1-month high. Learn more about Wegovy and its potential impact on the company!\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo Nordisk&#8217;s Wegovy Data Boosts Stock to 1-Month High\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\",\"name\":\"Muzzammil Ahmad\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"caption\":\"Muzzammil Ahmad\"},\"description\":\"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/\",\"https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625\"],\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Novo Nordisk's Wegovy Data Boosts Stock to 1-Month High | Stock Target Advisor","description":"Novo Nordisk stock jumps on positive Wegovy data, hitting a 1-month high. Learn more about Wegovy and its potential impact on the company!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/","og_locale":"en_US","og_type":"article","og_title":"Novo Nordisk's Wegovy Data Boosts Stock to 1-Month High","og_description":"Novo Nordisk stock jumps on positive Wegovy data, hitting a 1-month high. Learn more about Wegovy and its potential impact on the company!","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2023-11-13T13:22:22+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/11\/Novo-Nordisks-Wegovy-Data-Boosts-Stock-to-1-Month-High.jpg","type":"image\/jpeg"}],"author":"Muzzammil Ahmad","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/x.com\/Muzzammil625","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"Muzzammil Ahmad","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/"},"author":{"name":"Muzzammil Ahmad","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8"},"headline":"Novo Nordisk&#8217;s Wegovy Data Boosts Stock to 1-Month High","datePublished":"2023-11-13T13:22:22+00:00","dateModified":"2023-11-13T13:22:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/"},"wordCount":413,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/","name":"Novo Nordisk's Wegovy Data Boosts Stock to 1-Month High | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2023-11-13T13:22:22+00:00","dateModified":"2023-11-13T13:22:22+00:00","description":"Novo Nordisk stock jumps on positive Wegovy data, hitting a 1-month high. Learn more about Wegovy and its potential impact on the company!","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/novo-nordisks-wegovy-data-boosts-stock-to-1-month-high\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Novo Nordisk&#8217;s Wegovy Data Boosts Stock to 1-Month High"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8","name":"Muzzammil Ahmad","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","caption":"Muzzammil Ahmad"},"description":"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.","sameAs":["https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/","https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625"],"url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/42622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=42622"}],"version-history":[{"count":2,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/42622\/revisions"}],"predecessor-version":[{"id":42626,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/42622\/revisions\/42626"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/42624"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=42622"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=42622"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=42622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}